陳拓榮張智凱Chih-Kai Chang生物醫學科學學系碩士班2026-03-189999-12-312014https://handle.ncl.edu.tw/11296/4h59tmhttps://scholars.csmu.edu.tw/handle/123456789/5872歐洲藥典(European Parmacopoeia)第八版於2013年7月15日出版,並於2014年1月1日起正式生效。在本次修定中新增藥品品項[18F] FLT。該藥物在國內外許多文獻中,已廣為被研究使用在臨床疾病之診治、腫瘤治療方法或治療效果之評估及在許多藥物開發過程中作為量化測定之工具,在臨床或研究上皆具有一定價值。目前依據中華民國藥事法相關規定,藉由申請藥品查驗登記以取得藥物許可證進而合法供應臨床使用必需由藥商提供,該藥物必需在合法藥廠生產且該藥廠必需符合相關規範如GMP 、PIC/S,並通過國內主管機關衛生福利部定期派員查核。國內因設置迴旋加速器時間、成本、市場及同位素半衰期等因素,目前共有九家迴旋加速器中心設置於醫學中心內。因此申請新品項上市必需符合“斷層掃描用正子放射同位素調製作業查核須知”,以美國藥典、歐洲藥典已收載為主。 本研究使用IBA Synthera合成系統,搭配由Huayi isotope公司所生產的FLT組件、及目前被全球迴旋加速器中心廣為使用的合成GE TracerLab MX合成器,並配置advanced biochemical compounds公司FLT組件生產 [18F]fluorothymidine組件生產[18F]FLT,產品參照歐洲藥典所規範[18F]fluorothymidine的檢驗方法、合格標準等進行檢驗。並探討藥品生產過程使用之合成方式、途徑、儀器、環境條件及配置之賦形劑,對於產品的影響。以及研究歐洲藥典(European Parmacopoeia)第八版所規範[18F]fluorothymidine品管檢驗方式及其它替代性品管方式的可能性。European Pharmacopoeia Eighth Edition was published in July 15 and replace d the 7th Edition on 1 January 2014. In this version adds a new radiotracer, [18F] fluorothymidine. [18F] fluorothymidine has been widely used in clinical diagnosis of disease, estimate the effect of tumor treatment and as a tool in the drug development process, quantify of it, all have a certain value in clinical and research, and has been published in domestic and foreign literature. According to the current Taiwan of the Pharmaceutical Affairs Law, the new drug application is required by Drug Company. , the drug manufacturers should submit the application to verify a new drug complied with relevant regulations, and obtain the drug license before it can legally supply to clinical practice. The drug should be produced on the qualified pharmaceutical company that conforms to the relevant specifications such as GMP, PIC / S, and be conducting regularly checks by the Ministry of Health and Welfare, the authority in Taiwan. Due to the time, cost, market and half-life of isotope and other factors, there are nine cyclotron centers set up in the medical centers of Taiwan. Because the commercial application for a new drug must conform "the checking notes of isotopes produced practice on positron emission tomography ", the main references are the United States Pharmacopoeia and the European Pharmacopoeia. The study used two kinds of processes produce [18F] fluorothymidine. One is IBA Synthera synthesis system, with the FLT components produced by the Huayi isotope company; the other is GE TracerLab MX synthesizer which is widely adopted by many cyclotron centers in the world with the FLT components produced by the advanced biochemical compounds company. The quality testing standards, according to the European Pharmacopoeia [18F] fluorothymidine test methods and acceptance criteria. The influence of products by the synthetic process of drug production methods, approaches, instruments, environmental conditions, and excipients, were disscussed in the thesis. That the quality control methods of [18F] fluorothymidine complied with the European Pharmacopoeia (8th edition) was focused in the text. We also propose experimental data shorten the time of quality control that may replace the method recommended by the European Pharmacopoeia.探討二種符合歐洲藥典〔氟-18〕胸腺嘧啶核苷規範的製程與縮短品管時間的替代方法thesis